Current Assets
Alnylam Pharmaceuticals·Balance Sheet Statement·11 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Work in process | $66.5M | $69.9M | $65.0M | $54.0M | $43.8M | $35.5M | $65.1M | $65.5M |
| Finished goods | $27.9M | $23.1M | $26.4M | $33.0M | $33.7M | $38.9M | $32.3M | $39.0M |
| Raw materials | $26.0M | $22.4M | $24.0M | $23.4M | $22.9M | $22.3M | $14.2M | $11.7M |
| Inventories | $84.0M | $76.0M | $78.5M | $65.6M | $71.7M | $75.4M | $82.7M | $84.0M |